Autonomix Medical

Q1 FY2027 EarningsQ1 FY27 results beat consensus on key profitability metrics despite remaining a pre-revenue development-stage entity. Net loss was $2.73M vs. $3.51M expected, while Diluted EPS of -$5.02 outperformed the -$6.41 consensus estimate. Operating expenses declined 19% YoY to $2.77M, primarily driven by a 31% reduction in G&A costs following stock option cancellations. However, cash runway remains a critical concern, with management estimating current resources will only fund operations into Q1 2027.